These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
730 related items for PubMed ID: 24670093
21. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology. Huang X, Zhang Y, Yin G, Pu X, Liao X, Huang Z, Chen X, Yao Y. J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516 [Abstract] [Full Text] [Related]
22. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel. Emami J, Rezazadeh M, Hasanzadeh F, Sadeghi H, Mostafavi A, Minaiyan M, Rostami M, Davies N. Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319 [Abstract] [Full Text] [Related]
23. In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy. Guo P, Song S, Li Z, Tian Y, Zheng J, Yang X, Pan W. Int J Pharm; 2015 Sep; 486(1-2):356-66. PubMed ID: 25840274 [Abstract] [Full Text] [Related]
24. Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel. Zhao Y, Li J, Yu H, Wang G, Liu W. Int J Pharm; 2012 Jul 01; 430(1-2):282-91. PubMed ID: 22484705 [Abstract] [Full Text] [Related]
25. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B, Qu Y, Huang Y, Zhang L, Chen X, Long C, He Y, Ou C, Qian Z. Int J Pharm; 2016 Mar 16; 500(1-2):345-59. PubMed ID: 26794876 [Abstract] [Full Text] [Related]
26. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. Park EK, Kim SY, Lee SB, Lee YM. J Control Release; 2005 Dec 05; 109(1-3):158-68. PubMed ID: 16263189 [Abstract] [Full Text] [Related]
27. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells. Cai L, Qiu N, Li X, Luo K, Chen X, Yang L, He G, Wei Y, Chen L. Int J Pharm; 2011 Apr 15; 408(1-2):173-82. PubMed ID: 21277964 [Abstract] [Full Text] [Related]
28. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Tong SW, Xiang B, Dong DW, Qi XR. Int J Pharm; 2012 Sep 15; 434(1-2):413-9. PubMed ID: 22698861 [Abstract] [Full Text] [Related]
29. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Angelopoulou A, Voulgari E, Diamanti EK, Gournis D, Avgoustakis K. Eur J Pharm Biopharm; 2015 Jun 15; 93():18-26. PubMed ID: 25817600 [Abstract] [Full Text] [Related]
30. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. Zeng F, Lee H, Allen C. Bioconjug Chem; 2006 Jun 15; 17(2):399-409. PubMed ID: 16536472 [Abstract] [Full Text] [Related]
31. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth. Naksuriya O, Shi Y, van Nostrum CF, Anuchapreeda S, Hennink WE, Okonogi S. Eur J Pharm Biopharm; 2015 Aug 15; 94():501-12. PubMed ID: 26134273 [Abstract] [Full Text] [Related]
32. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. Nam JP, Park SC, Kim TH, Jang JY, Choi C, Jang MK, Nah JW. Int J Pharm; 2013 Nov 30; 457(1):124-35. PubMed ID: 24076228 [Abstract] [Full Text] [Related]
33. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy. Zhang J, Li Y, Gao W, Repka MA, Wang Y, Chen M. Expert Opin Drug Deliv; 2014 Sep 30; 11(9):1367-80. PubMed ID: 24935153 [Abstract] [Full Text] [Related]
34. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Sezgin Z, Yüksel N, Baykara T. Eur J Pharm Biopharm; 2006 Nov 30; 64(3):261-8. PubMed ID: 16884896 [Abstract] [Full Text] [Related]
35. Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation. Saadat E, Amini M, Khoshayand MR, Dinarvand R, Dorkoosh FA. Int J Pharm; 2014 Nov 20; 475(1-2):163-73. PubMed ID: 25148729 [Abstract] [Full Text] [Related]
36. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. Ashok B, Arleth L, Hjelm RP, Rubinstein I, Onyüksel H. J Pharm Sci; 2004 Oct 20; 93(10):2476-87. PubMed ID: 15349957 [Abstract] [Full Text] [Related]
37. Peptide GE11-Polyethylene Glycol-Polyethylenimine for targeted gene delivery in laryngeal cancer. Ren H, Zhou L, Liu M, Lu W, Gao C. Med Oncol; 2015 Jul 20; 32(7):185. PubMed ID: 26008151 [Abstract] [Full Text] [Related]
38. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers. Zhu J, Zhou Z, Yang C, Kong D, Wan Y, Wang Z. J Biomed Mater Res A; 2011 Jun 15; 97(4):498-508. PubMed ID: 21509931 [Abstract] [Full Text] [Related]
39. Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS. Yan H, Wei P, Song J, Jia X, Zhang Z. J Pharm Pharmacol; 2016 Oct 15; 68(10):1290-8. PubMed ID: 27465923 [Abstract] [Full Text] [Related]
40. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro. Wei Y, Xu S, Wang F, Zou A, Zhang S, Xiong Y, Cao S, Zhang Q, Wang Y, Jiang X. J Pharm Sci; 2015 Jan 15; 104(1):165-77. PubMed ID: 25421492 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]